Johnson & Johnson Vaccine Is 66% Effective In Preventing Moderate To Severe COVID-19

. Michael Ciaglo/Getty Images

toggle caption

hide caption

Pharmacy specialist Sara Berech prepared a dose of the Johnson & & Johnson COVID-19 vaccine in December for a medical trial that consists of Rocky Mountain Regional VA Medical Center in Aurora, Colo

Michael Ciaglo/Getty Images

The company says it plans to use to the Food and Drug Administration for emergency situation use permission to distribute the vaccine.

An international research study of nearly 44,000 discovered that the COVID-19 vaccine made by Johnson & & Johnson is 66% effective in avoiding moderate to serious illness.

The study was conducted in the U.S., Latin America and South Africa. The vaccine did much better at preventing illness in this country– 72% percent– and less well in South Africa– 57% effectiveness. The efficacy seen in Latin America was 66%.

The vaccine did show complete security versus COVID-19 major adequate to require hospitalization, according to a press release from the business. The vaccine was 85% percent efficient in avoiding extreme types of the illness.

” These topline outcomes with a single-shot COVID-19 vaccine candidate represent an appealing moment,” stated a declaration by Dr. Paul Stoffels, chief clinical officer of Johnson & & Johnson. “A one-shot vaccine is thought about by the World Health Organization to be the very best alternative in pandemic settings, enhancing distribution, compliance and access.”

. Michael Ciaglo/Getty Images

The study was conducted in the U.S., Latin America and South Africa. The vaccine did much better at avoiding illness in this nation– 72% percent– and less well in South Africa– 57% efficacy. The efficacy seen in Latin America was 66%.

The Johnson & & Johnson vaccine is offered as a single shot, unlike the vaccines from Moderna and Pfizer that require 2 shots offered weeks apart. The Johnson & & Johnson vaccine also does not need ultracold storage.

The South African results are troubling since the coronavirus spreading there and that has now been found in the U.S. raising issues that the vaccines established up until now might not work also versus it.

Pharmacy specialist Sara Berech prepared a dosage of the Johnson & & Johnson COVID-19 vaccine in December for a medical trial that includes Rocky Mountain Regional VA Medical Center in Aurora, Colo